Table 3. Age-specific and age-adjusted prevalence of MetS in Kazakh adults based on criteria of the IDF, ATP III, and JIS.
| Age-group | Total (n = 3900) | Men (n = 1547) | Women (n = 2353) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ATPIII | IDF | JIS | ATP | IDF | JIS | ATP III | IDF | JIS | |
| 18–24 | 3.5 (10) | 11(3.8) | 25(8.7) | 2(2.0) | 1(1.0) | 4(4.1) | 8(4.2) | 10(5.3) | 21(11.1) |
| 25–34 | 46(6.5) | 81(11.5) | 110(15.6) | 19(6.6) | 29(10.1) | 49(17.1) | 27(6.4) | 52(12.4) | 61(14.6) |
| 35–44 | 113(11.4) | 178(17.9) | 212(21.3) | 35(9.8) | 57(16.0) | 82(23.0) | 78(12.2) | 121(18.9) | 130(20.3) |
| 45–54 | 191(19.4) | 291(29.5) | 333(33.8) | 59(15.4) | 98(25.6) | 124(32.4) | 132(21.9) | 193(32.1) | 209(34.7) |
| 55–64 | 190(28.3) | 274(40.8) | 302(44.9) | 66(21.1) | 108(34.5) | 129(41.2) | 124(34.5) | 166(46.2) | 173(48.2) |
| ≥65 | 27.1 (69) | 99(38.8) | 104(40.8) | 20(18.0) | 31(27.9) | 34(30.6) | 49(34) | 68(47.2) | 70(48.6) |
| Total- crude | 15.9 (619) | 934(23.9) | 1086(27.8) | 201(13.0) | 324(20.9) | 422(27.3) | 418(17.8) | 610(25.9) | 664(28.2) |
| Age- adjusted | 13.8 | 20.9 | 24.8 | 11 | 17.4 | 23.5 | 15.9 | 23.5 | 25.9 |
Data expressed by % (n).